Aldagen (ALDH) Files $80.5M IPO
Aldagen (Nasdaq: ALDH) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $80.5 million. The company plans to list on the NASDAQ under the stock symbol "ALDH".
The offering is being made through Cowen and Company, Wachovia Securities and Pacific Growth Equities.
Aldagen is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. [BCS]
Stocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
